USANA HEALTH SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
USANA HEALTH SCIENCES, INC. (USNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $35.41 per share for the 12-month period ending 2019-12-28, per its 10-K filed 2020-02-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2020-02-25
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2015-04-04 was $30.49, a 71.97% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2014-03-29 was $17.73, a 32.91% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2013-03-30 was $13.34.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $35.41.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $22.99, a 2.17% decline from fiscal 2016.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $23.50, a 148.41% increase from fiscal 2015.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $9.46, a 46.22% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-28 | $35.41 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | $22.99 10-K · filed 2019-02-26 | ||||
| 2016-01-02 | $23.50 10-K · filed 2018-02-28 | $46.99 10-K · filed 2016-03-01 | |||
| 2015-10-03 | $47.43 10-Q · filed 2015-11-12 | ||||
| 2015-07-04 | $31.80 10-Q · filed 2015-08-12 | ||||
| 2015-04-04 | $30.49 10-Q · filed 2015-05-13 | ||||
| 2015-01-03 | $9.46 10-K · filed 2017-03-01 | $18.91 10-K · filed 2015-03-17 | |||
| 2014-09-27 | $17.92 10-Q · filed 2015-11-12 | ||||
| 2014-06-28 | $17.73 10-Q · filed 2015-08-12 | ||||
| 2014-03-29 | $17.73 10-Q · filed 2015-05-13 | ||||
| 2013-12-28 | $17.59 10-K · filed 2016-03-01 | ||||
| 2013-09-28 | $16.01 10-Q · filed 2014-11-06 | ||||
| 2013-03-30 | $13.34 10-Q · filed 2014-08-05 | ||||
| 2012-12-29 | $15.35 10-K · filed 2015-03-17 | ||||
| 2011-12-31 | $12.40 10-K · filed 2014-03-13 | ||||
| 2011-01-01 | $17.09 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |